News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Opinion|Videos|May 16, 2024

Definition of Narcolepsy and Unmet Needs

Karl Doghramji, MD, FAASM, DFAPA, and Chelsie Monroe, MSN, APN, PMHNP-BC, utilize their expertise in the management of sleep disorders to provide an overview of narcolepsy, educating the audience on how to recognize this condition in their patient populations.

Episodes in this series

Video 1 - "Definition of Narcolepsy and Unmet Needs"

EP. 1 Definition of Narcolepsy and Unmet Needs

Video 2 - "Pathophysiology of Narcolepsy and the Role of Orexins"

EP. 2 Pathophysiology of Narcolepsy and the Role of Orexins

Video 2 - "Diagnostic Practices for Narcolepsy"

EP. 3 Diagnostic Practices for Narcolepsy

Video 2 - "Narcolepsy Evaluation, Management, and Treatment Considerations"

EP. 4 Narcolepsy Evaluation, Management, and Treatment Considerations

Video 5 - "Clinical Treatment Strategies for a Patient Suffering from EDS and Hypnagogic Hallucinations"

EP. 5 Clinical Treatment Strategies for a Patient Suffering from EDS and Hypnagogic Hallucinations

Video 6 - "Patient-Centered Approach: Adapting Narcolepsy Treatments to Address Adverse Events and Mitigate Misuse Risks"

EP. 6 Patient-Centered Approach: Adapting Narcolepsy Treatments to Address Adverse Events and Mitigate Misuse Risks

Video 7 - "Complex Case of a 23-Year-Old Male College Student Suffering From Narcolepsy Symptoms"

EP. 7 Complex Case of a 23-Year-Old Male College Student Suffering From Narcolepsy Symptoms

Video 8 - "Treatment Augmentation in a Patient with Narcolepsy and ADHD"

EP. 8 Treatment Augmentation in a Patient with Narcolepsy and ADHD

Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA

EP. 9 Considerations for the Management of Pediatric Patients with Narcolepsy

Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA

EP. 10 Non-Pharmacologic Interventions for Pediatric Patients with Narcolepsy

Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA

EP. 11 Clinical Pearls for the Management of Patients Suffering from Narcolepsy

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

Experts featured in this series.

Multidisciplinary Approaches to Long-Term Narcolepsy Care

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 22nd 2026

Experts featured in this series.

Optimizing Narcolepsy Treatment Through Polypharmacy

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 15th 2026

Experts featured in this series.

Assessing DEA Scheduling and Emerging Therapies in Narcolepsy

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 15th 2026

Experts featured in this series.

Evaluating Pitolisant and Other Pharmacologic Treatment Options for Narcolepsy

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 8th 2026

Experts featured in this series.

Narcolepsy Treatment Considerations in Pediatric Patients

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 8th 2026

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Trending on Psychiatric Times

Zolpidem: Restoring Sleep and Slowing Alzheimer Disease Progression

GABA Deficits and Sleep Disruption in Early Alzheimer Disease

Keeping Up To Date With Bipolar Disorder

Sleep Changes Across the Lifespan: A Multidimensional Construct

No Screens Before Bed: Teen Smartphone Use at Bedtime Predicts Overnight Phone Activity